Diamondback Energy
FANG
$175.75
-0.58%
Diamondback Energy, Inc. is an independent crude oil and natural gas exploration and production company operating as a pure-play in the U.S. Permian Basin, with its core position concentrated in the Midland sub-basin where it drills and produces oil, natural gas liquids, and natural gas. The company has established itself as a top-tier independent producer through disciplined acquisition and operational excellence, and its September 2024 completion of the roughly $26 billion Endeavor Energy Resources merger added approximately 470,000 net acres and effectively doubled its total acreage position, cementing its scale leadership among Permian peers. The current investor narrative is dominated by the post-Endeavor integration story and the company's ability to convert a much larger production base into free cash flow, with recent headlines highlighting Q3 2026 earnings that significantly exceeded expectations on strong production and cost control. At the same time, the debate is increasingly two-sided: bulls point to structurally elevated oil prices and Diamondback's low-cost Permian inventory as a multi-year cash flow engine, while bears focus on the sharp oil-price sensitivity embedded in the equity, evidenced by the pullback following the April 2026 Strait of Hormuz reopening and crude's 14% one-day plunge, plus a recent Bernstein downgrade to Market Perform that signals growing caution on the risk/reward at current levels.…
FANG
Diamondback Energy
$175.75
Related headlines
Investment Opinion: Should I buy FANG Today?
Rating: Buy (moderate conviction). The core thesis is that Diamondback trades at 8.49x consensus forward EPS of $19.01 and roughly 14.9% trailing FCF yield ($6.461 billion FCF on a $43.46 billion market cap) for a low-cost, scale-leading Permian pure-play whose Q3 2026 revenue grew 38.4% year over year to $5.431 billion — a discount that appears to price in oil-price pessimism rather than the post-Endeavor cash-generation engine. This is anchored by a 26 Buy / 6 Hold / 0 Sell consensus (mean 1.56) and an average target of $237.43, implying 28.4% upside from $184.93, with even the lowest target of $192.00 sitting 3.8% above the current price.
The supporting evidence is broad: forward PE of 8.49x versus a 26.2x trailing multiple distorted by the Q4 2025 $3.203 billion charge; EV/EBITDA of 8.14x, price-to-book of 1.18x, and price-to-cash-flow of 4.96x all at or below typical large-cap E&P levels; Q3 2026 net income of $1.603 billion on a 29.5% net margin and 67.2% EBITDA margin; and quarterly FCF of $1.573 billion, $2.593 billion, and $895 million across Q3, Q2, and Q1 2026 that comfortably covered capex of $1.026 billion, $996 million, and $933 million while still funding $309 million of dividends and $251 million of buybacks in Q3. Debt-to-equity of 0.402 keeps leverage conservative, and the 2.66% dividend yield is covered by that FCF despite a 69.5% payout ratio.
The biggest risks that could invalidate the thesis are (1) a sustained crude decline — the April 2026 Hormuz reopening produced a 14% one-day oil plunge and a sharp FANG selloff, and oil E&P is $9.07 billion of revenue versus $487 million NGLs and $151 million gas; (2) momentum and sentiment deterioration, with the stock down 6.37% over one month and 8.66% over three months and relative strength versus SPY of -4.11% and -5.83%, plus Bernstein's November 12, 2026 downgrade to Market Perform and Morgan Stanley's August 2026 cut to Equal Weight; and (3) earnings-quality noise from one-time charges that leave trailing EPS at $0.038 and ROE at 4.50%. This Buy would upgrade to a higher-conviction stance if the stock reclaims the $216.90 52-week high on stable crude, and would downgrade to Hold if it breaks the $178 tactical floor or if forward EPS estimates slip below roughly $16.54 (the low end of the consensus range). Valuation verdict: undervalued relative to its own history (PS of 2.89x near the bottom of a 8.62x–16.05x multi-year band; P/B of 1.18x near the low end of 0.94x–2.10x) and at a discount to peers — but that discount is conditional on oil holding.
Sign up to view all
FANG 12-Month Price Forecast
The forward view is constructive but conditional: at 8.49x forward EPS of $19.01 and roughly 14.9% FCF yield, FANG is priced for oil pessimism rather than for the scale and low-cost position the Endeavor merger created, and the 26-to-0 Buy/Sell split with 28.4% average upside says the sell-side agrees. The base case (55%) has the stock grinding toward the $237.43 consensus average as the Q4 2025 charge rolls off and clean quarterly EPS of $5.69–$6.65 annualizes near consensus, while the bear case (20%) is a crude rollover that retests the $139.41 low. The key swing factor is oil: the April 2026 Hormuz reopening showed a 14% one-day crude plunge can hit the equity directly, and the recent -6.37% one-month move with -4.11% relative strength versus SPY shows that sensitivity is live. I would upgrade to high confidence if the stock reclaims the $216.90 52-week high on stable crude or if forward EPS estimates hold above $19, and downgrade to neutral if it breaks the $178 tactical floor or if consensus EPS drifts toward the $16.54 low end.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Diamondback Energy's 12-month outlook, with a consensus price target around $238.55 and implied upside of +35.7% versus the current price.
Average Target
$238.55
31 analysts
Implied Upside
+35.7%
vs. current price
Analyst Count
31
covering this stock
Price Range
$192 - $266
Analyst target range
Coverage is deep and overwhelmingly constructive, with 30 analysts and a distribution of 26 Buy, 6 Hold, and 0 Sell, producing a consensus recommendation of "buy" and a recommendation mean of 1.56 on a 1-to-5 scale. The average target price of $237.43 implies roughly 28.4% upside from the current $184.93, a spread that leans clearly bullish and stands in sharp contrast to the stock's recent 6.37% one-month decline — suggesting the sell-side views the pullback as an opportunity rather than a deterioration in fundamentals. The consensus EPS estimate of $19.01 (range $16.54 to $21.78) and revenue estimate of $17.41 billion (range $15.66 billion to $19.35 billion) underpin that constructive stance.
The full target range of $192.00 to $269.00 is moderately wide, with the low target sitting just 3.8% above the current price — implying even the most cautious analyst sees limited downside — while the high target of $269.00 implies about 45.5% upside and would require either sustained elevated oil prices or multiple expansion toward the upper end of the historical band. Signal strength is mixed: recent institutional actions include a Bernstein downgrade to Market Perform from Outperform on November 12, 2026, and a Morgan Stanley cut to Equal Weight from Overweight in August 2026, offset by reiterated Buy/Overweight ratings from UBS, Truist, Wells Fargo, and RBC and a Strong Buy from Raymond James. The pattern of two downgrades against a still-heavily-bullish consensus suggests the Street is trimming enthusiasm on valuation and oil-price risk without abandoning the thesis, and the tight low-end of the target range indicates stronger conviction on downside support than on the magnitude of upside.
Bulls vs Bears: FANG Investment Factors
The bull case currently rests on stronger hard evidence: an 8.49x forward PE, a 14.9% FCF yield, 38.4% revenue growth, and a 26-to-0 Buy/Sell analyst split with 28.4% average upside all point to a cheap, cash-generative producer. The bear case is real but more conditional — it hinges on oil prices rolling over, as the April 2026 Hormuz-driven 14% crude plunge demonstrated, and on the recent momentum breakdown (-6.37% one month, -8.66% three months) reflecting that sensitivity rather than any deterioration in operating results. The single most important tension is whether structurally elevated oil prices persist long enough for the Endeavor-enhanced production base to convert into sustained free cash flow at current levels; if crude holds, the discount to peers looks unjustified, but if it softens, the 69.5% payout ratio and commodity-levered revenue mix leave little room for error. On balance, the evidence favors the bulls modestly, but the margin of safety is entirely a function of the oil price.
Bullish
- Forward PE of 8.49x is deeply discounted: At $184.93, FANG trades at just 8.49x consensus forward EPS of $19.01, versus a 26.2x trailing multiple distorted by the Q4 2025 charge. EV/EBITDA of 8.14x and price-to-book of 1.18x sit at or below typical large-cap E&P levels, implying the market is pricing in pessimistic oil realizations rather than the company's low-cost Permian position.
- Revenue up 38.4% YoY post-Endeavor: Q3 2026 revenue of $5.431 billion grew 38.4% from Q3 2025's $3.924 billion, and the run-rate has stepped up from Q1 2026's $4.240 billion to $5.431 billion. The Endeavor merger added roughly 470,000 net acres and doubled the acreage base, giving the company a materially larger production engine to convert into cash flow.
- FCF yield near 14.9% funds returns: Trailing free cash flow of $6.461 billion against a $43.46 billion market cap implies roughly a 14.9% FCF yield. Quarterly FCF of $1.573 billion, $2.593 billion, and $895 million comfortably covered capex of $1.026 billion, $996 million, and $933 million, while the company still paid $309 million in dividends and repurchased $251 million of stock in Q3.
- Analyst consensus 26 Buy, 0 Sell: Coverage of 30 analysts shows 26 Buy, 6 Hold, and zero Sell, with a recommendation mean of 1.56 and an average target of $237.43 implying 28.4% upside. Even the lowest target of $192.00 sits 3.8% above the current price, indicating strong conviction on downside support.
Bearish
- Oil-price sensitivity is the core risk: The April 2026 Strait of Hormuz reopening triggered a 14% one-day crude plunge and a sharp FANG pullback, demonstrating how directly the equity tracks oil. With oil E&P contributing $9.07 billion of revenue versus $487 million from NGLs and $151 million from natural gas, crude realizations dominate the P&L and can reverse the top line quickly.
- Momentum has broken down: The stock is down 6.37% over one month and 8.66% over three months despite a positive 28.09% one-year return. Relative strength versus SPY is -4.11% over one month and -5.83% over three months, meaning this is genuine idiosyncratic weakness rather than beta-driven drift, and the 6-month change of -9.15% confirms the intermediate trend is corrective.
- Two downgrades signal valuation caution: Bernstein cut FANG to Market Perform from Outperform on November 12, 2026, and Morgan Stanley moved to Equal Weight from Overweight in August 2026. The pattern of two downgrades against a still-bullish consensus suggests the Street is trimming enthusiasm on valuation and oil-price risk without abandoning the thesis.
- Earnings quality is noisy and charge-laden: Trailing EPS of just $0.038 and a 26.2x trailing PE reflect the Q4 2025 loss of $1.458 billion driven by a $3.203 billion other-expense charge, plus a depressed Q1 2026 EPS of $0.08. ROE of 4.50% and ROA of 2.07% look weak on a trailing basis, and the negative PEG of -0.42 is a mechanical artifact of that distortion.
FANG Technical Analysis
Diamondback is in a choppy, range-bound consolidation rather than a clean trend, with the stock up 28.09% over the trailing year but sitting at $184.93, which is roughly 60.4% of its 52-week range of $139.41 to $216.90. That positioning — closer to the middle of the band than either extreme — reflects a market that has repeatedly tested both the low-$210s and the high-$170s without resolving direction, and it implies neither momentum-chasing nor deep-value dynamics are currently in control. The 21.39% year-to-date gain confirms the longer-term bid remains intact, but the failure to hold the upper range suggests overhead supply is real.
Short-term momentum has clearly decelerated and diverged from the longer-term uptrend: the stock is down 6.37% over the past month and 8.66% over three months, versus a still-positive 28.09% one-year return. This divergence is meaningful — the 1-month relative strength versus SPY is -4.11% and the 3-month relative strength is -5.83%, meaning FANG has underperformed the market even as SPY itself fell 2.26% and 2.83% over those windows, so this is genuine idiosyncratic weakness rather than beta-driven drift. The most recent action offers a tentative stabilization signal, with the stock rebounding 1.50% on the latest session to $184.93 from a November 10 low close of $178.08, but the 6-month change of -9.15% and 6-month relative strength of -11.28% show the intermediate trend is still corrective.
Key technical levels are well defined: support sits at the 52-week low of $139.41, with a nearer tactical floor around the $178 area that has held on three consecutive closes in early November, while resistance is the 52-week high of $216.90, a level the stock approached at $212.08 on October 30 before reversing sharply. A breakout above $216.90 would signal a fresh leg higher and likely validate the bullish consensus targets, whereas a breakdown below $178 would open the door toward the $139.41 low and confirm the multi-month downtrend. Notably, the beta of 0.468 indicates the stock has historically moved with less than half the volatility of the broader market, which is unusual for an E&P name and argues for larger position sizing on a volatility-adjusted basis — though the -19.53% max drawdown and 3.57 short ratio remind investors that commodity-driven gap risk can overwhelm low beta during oil-price shocks.
Beta
0.47
0.47x market volatility
Max Drawdown
-19.5%
Largest decline past year
52-Week Range
$139-$217
Price range past year
Annual Return
+20.2%
Cumulative gain past year
| Period | FANG Return | S&P 500 |
|---|---|---|
| 1m | -12.5% | -9.7% |
| 3m | -16.6% | -9.9% |
| 6m | -12.4% | -7.5% |
| 1y | +20.2% | +4.7% |
| ytd | +15.4% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FANG Fundamental Analysis
Revenue is growing robustly and the trajectory is improving: Q3 2026 revenue of $5.431 billion represents 38.4% year-over-year growth versus Q3 2025's $3.924 billion, and the sequential path from Q1 2026's $4.240 billion to Q2's $5.562 billion to Q3's $5.431 billion shows the business has stepped up to a materially higher run-rate post-Endeavor. The segment mix underscores the oil-levered nature of the story, with oil exploration and production contributing $9.07 billion, natural gas liquids $487 million, natural gas $151 million, and purchased oil $536 million — meaning crude realizations dominate the P&L and revenue growth is highly sensitive to both volume gains from the merger and oil price. The growth trend supports the investment case for scale-driven cash generation, but it also means the top line can reverse quickly if crude rolls over, as the Q4 2025 revenue dip to $3.376 billion demonstrated.
Profitability is strong at the operating level but noisy at the net line: Q3 2026 net income was $1.603 billion on a 29.5% net margin, with gross margin of 46.0% and operating margin of 32.7%, and EBITDA of $3.647 billion representing a 67.2% EBITDA margin. Margins have been volatile across quarters — gross margin moved from 68.7% in Q1 2026 to 45.2% in Q2 to 46.0% in Q3 — largely reflecting commodity realizations and one-time items rather than structural deterioration, while the Q4 2025 loss of $1.458 billion (EPS -$5.11) was driven by a $3.203 billion other-expense charge, not operating weakness. The trailing EPS of $0.038 is an artifact of that charge and the depressed Q1 2026 print of $0.08, so investors should anchor on the normalized quarterly EPS of $5.69 and $6.65 in Q2/Q3 2026, which are consistent with the consensus forward EPS estimate of $19.01.
Balance sheet and cash flow metrics are solid for an E&P of this scale: debt-to-equity is a conservative 0.402, the current ratio of 0.416 reflects the working-capital-light nature of upstream operations rather than distress, and trailing free cash flow of $6.461 billion against a $43.46 billion market cap implies an FCF yield of roughly 14.9%. Quarterly free cash flow has been consistently positive at $1.573 billion, $2.593 billion, and $895 million across Q3, Q2, and Q1 2026, comfortably covering capital expenditure of $1.026 billion, $996 million, and $933 million respectively, while the company simultaneously returned cash via $309 million in dividends and $251 million in buybacks in Q3 alone. ROE of 4.50% and ROA of 2.07% look low on a trailing basis because of the Q4 2025 charge, but the underlying cash generation — with operating cash flow of $2.599 billion in Q3 2026 — indicates the company funds growth internally and carries manageable leverage, with a dividend yield of 2.66% and a payout ratio of 69.5% that is elevated but supported by FCF.
Quarterly Revenue
$5.4B
2026-09
Revenue YoY Growth
+38.4%
YoY Comparison
Gross Margin
46.0%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FANG Overvalued?
Because trailing net income is positive but distorted by one-time charges (trailing EPS of just $0.038), the trailing PE of 26.2x is not a meaningful anchor; the more informative metric is the forward PE of 8.49x based on consensus EPS of $19.01, which is the primary valuation lens here. The enormous gap between the 26.2x trailing and 8.49x forward multiple implies the market expects a dramatic earnings normalization as the Q4 2025 charge rolls off and the Endeavor-enhanced production base converts into clean profitability — a gap that also flags how sensitive the multiple is to the trailing-period distortion rather than to any genuine re-rating.
On peer comparison, Diamondback screens cheap across most metrics: EV/EBITDA of 8.14x, EV/Sales of 3.99x, price-to-book of 1.18x, and price-to-cash-flow of 4.96x, all of which sit at or below typical large-cap E&P levels, while the 2.89x PS ratio and 8.49x forward PE are consistent with a low-cost Permian producer trading at a discount to the broader market. The premium/discount question is largely answered by the 2.66% dividend yield and roughly 14.9% FCF yield, which suggest the market is pricing in commodity-price risk and integration execution rather than awarding a growth multiple — a discount that appears justified only if oil prices soften, and arguably too wide given the company's low-cost position and scale. The negative PEG ratio of -0.42 is a mechanical artifact of the trailing earnings distortion and should be disregarded.
Historical context reinforces the discount thesis: the stock's own PE history shows 8.08x in Q3 2026, 6.61x in Q2 2026, and a 618x spike in Q1 2026 from the depressed earnings base, while PS has ranged from 8.62x (Q3 2022) to 16.05x (Q1 2024) and now sits at 2.89x — near the bottom of its multi-year band. Price-to-book at 1.18x is likewise near the low end of its historical 0.94x–2.10x range, and EV/EBITDA of 8.14x compares favorably to the 17.58x enterprise-value multiple recorded in Q3 2026 historical ratios. The read-through is that the market is pricing in cautious-to-pessimistic expectations on oil realizations and post-merger execution, leaving room for multiple expansion if free cash flow holds near current levels.
PE
26.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~14x
vs. Industry Avg
12.8x
Industry PE ~12.8x*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on commodity concentration and earnings quality. Oil E&P contributes $9.07 billion of revenue versus just $487 million from NGLs and $151 million from natural gas, so crude realizations dominate the P&L and the top line can reverse quickly — Q4 2025 revenue fell to $3.376 billion from $4.240 billion in Q1 2026. The Q4 2025 net loss of $1.458 billion (EPS -$5.11) was driven by a $3.203 billion other-expense charge, leaving trailing EPS at $0.038 and ROE at 4.50%, which shows how one-time items can swamp reported profitability. The 69.5% payout ratio on a 2.66% dividend yield is elevated for a cyclical producer, and the 0.416 current ratio offers limited working-capital cushion if cash flow compresses.
Market and competitive risks are dominated by oil-price beta and valuation compression. Despite a reported beta of 0.468, the equity's realized sensitivity to crude is severe — the April 2026 Strait of Hormuz reopening triggered a 14% one-day crude plunge and a sharp FANG selloff, and the stock has since fallen 6.37% over one month and 8.66% over three months with relative strength versus SPY of -4.11% and -5.83%. Two downgrades — Bernstein to Market Perform on November 12, 2026, and Morgan Stanley to Equal Weight in August 2026 — signal that the Street is trimming enthusiasm on valuation and oil-price risk even as 26 of 30 analysts remain Buy-rated. The 8.49x forward PE and 8.14x EV/EBITDA already embed a discount to peers, so multiple compression from here would require a genuine deterioration in the oil outlook rather than simple de-rating.
The worst-case scenario is a sustained crude price decline that compresses realizations, forces capex cuts, and pressures the dividend simultaneously. In that chain, the stock would likely retest its 52-week low of $139.41, which represents roughly -24.6% from the current $184.93, and the -19.53% max drawdown shows how quickly commodity-driven gap risk can materialize. The analyst low target of $192.00 sits 3.8% above the current price and offers little downside protection in a true bear case, so investors should anchor on the $139.41 low as the realistic floor. A move below the tactical $178 support that held on three consecutive closes in early November would open the door toward that low and confirm the multi-month downtrend.
FAQ
The most severe risk is commodity concentration: oil E&P is $9.07 billion of revenue versus $487 million from NGLs and $151 million from gas, and the April 2026 Hormuz reopening produced a 14% one-day crude plunge that hit the equity directly. Second is earnings-quality and balance-sheet flexibility risk — the Q4 2025 net loss of $1.458 billion (EPS -$5.11) from a $3.203 billion charge left trailing ROE at 4.50%, and the 0.416 current ratio plus a 69.5% payout ratio leave little room if cash flow compresses from $6.461 billion. Third is sentiment and momentum risk, with the stock down 8.66% over three months, relative strength versus SPY of -5.83%, and two downgrades (Bernstein to Market Perform in November 2026, Morgan Stanley to Equal Weight in August 2026) showing the Street trimming enthusiasm. Fourth is valuation-compression risk if the oil outlook deteriorates — the 8.49x forward PE already embeds a discount, so further de-rating would require genuine deterioration rather than simple multiple normalization.
The scenario framework assigns a 55% probability to the base case of $192.00–$237.43, in which oil trades in a moderate range, revenue holds near the $5.4–5.6 billion quarterly run-rate, consensus EPS of $19.01 and revenue of $17.41 billion are broadly met, and the stock grinds toward the $237.43 average target without clearing the $216.90 52-week high. The bull case (25%) targets $237.43–$269.00 and requires structurally elevated crude or multiple expansion as the Q4 2025 charge rolls off reported earnings. The bear case (20%) targets $139.41–$192.00 and assumes a sustained crude decline that compresses realizations and pressures the dividend simultaneously. The base case is most likely, and its key assumption is that crude stays range-bound rather than breaking down — the analyst low target of $192.00 offers only 3.8% downside protection, so the true bear-case floor is the 52-week low.
The primary lens is the 8.49x forward PE on consensus EPS of $19.01, which is far more meaningful than the 26.2x trailing multiple distorted by the Q4 2025 $3.203 billion charge that left trailing EPS at $0.038. Supporting metrics — 8.14x EV/EBITDA, 3.99x EV/Sales, 1.18x price-to-book, and 4.96x price-to-cash-flow — sit at or below typical large-cap E&P levels, and the 2.89x PS ratio is near the bottom of a historical 8.62x–16.05x band while P/B is near the low end of its 0.94x–2.10x range. The roughly 14.9% FCF yield implies the market expects cautious-to-pessimistic oil realizations and post-Endeavor integration friction rather than awarding any growth premium. In short, the stock looks undervalued relative to its own history and at a discount to peers, but that discount is a direct function of commodity risk rather than a free lunch.
On a risk/reward basis the setup is favorable but conditional: at $184.93 the stock trades at 8.49x forward EPS of $19.01 and roughly a 14.9% FCF yield, while the $237.43 average analyst target implies 28.4% upside and even the $192.00 low target sits 3.8% above spot. The downside case is real — a crude rollover toward the $139.41 52-week low would mean about -24.6% — and the stock is already down 6.37% over one month with -4.11% relative strength versus SPY, so momentum is not on the buyer's side today. The 26 Buy / 6 Hold / 0 Sell split and 2.66% dividend yield provide support, but the 69.5% payout ratio leaves limited cushion if free cash flow compresses from $6.461 billion. It is a good buy for investors who want discounted, cash-generative energy exposure and can tolerate oil-price volatility, ideally scaled in near the $178 tactical floor rather than chased after a rally.
FANG fits a medium-to-long-term holding period of at least 12–24 months rather than a short-term trade, because the thesis depends on crude staying structurally elevated long enough for the Endeavor-doubled acreage base to convert into sustained free cash flow near the current $6.461 billion trailing level. The 2.66% dividend yield and $251 million of Q3 2026 buybacks provide a total-return floor that rewards patience, and the beta of 0.468 argues for larger position sizing on a volatility-adjusted basis. However, the -19.53% max drawdown, 3.57 short ratio, and demonstrated gap risk (the 14% one-day crude plunge in April 2026) mean short-term holders face sharp, headline-driven swings with no earnings catalyst between quarters. Earnings visibility is decent at the operating level — Q2 and Q3 2026 EPS of $6.65 and $5.69 annualize near the $19.01 consensus — but reported results remain hostage to one-time charges and commodity marks, so a 12-month minimum horizon with staged entry near the $178 support is the most defensible approach.

